|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS AND ORIGINAL ARTICLES |
From Renal Section and Metabolism Research Laboratory, Veterans Administration Hospital and Department of Medicine, Neurology and Nutritional Science, University of Wisconsin, Madison, WI, USA.
Carnitine, a small-molecular-weight quarternary amine, is lost from the
plasma during hemodialysis in patients with chronic renal failure. Reports are
conflicting concerning plasma carnitine levels in patients on continuous
ambulatory peritoneal dialysis (CAPD). We studied 35 patients on CAPD for
varying durations (up to 70 months) and noted a significant elevation in
plasma levels of total carnitine, 62.98 ± 19.76 Uμmol/l; M
± SD) when compared to levels in healthy controls, 50.45
± 8.7 (p < .005). This elevation in total carnitine level was
due entirely to increases in esterified carnitine fractions in the patients
27.05 ± 11.8 when compared to control values, 7.93 ± 3.3
(p < .001). Plasma levels of free carnitine were similar in patients, 38.05
± 13.7 and controls, 42.5 ± 8.14. In nine patients
repeat plasma carnitine determinations 29 months after the initial studies
showed no significant changes. Despite loss of carnitine in the peritoneal
dialysate, plasma carnitine levels do not fall in patients on CAPD. At
present, no one knows why plasma levels of esterified car nitine are elevated
in patients on CAPD; this requires further study.
KEY WORDS: Carnitine; Carnitine-total; Carnitine free; Carnitine Esterified.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |